{
    "clinical_study": {
        "@rank": "41803", 
        "arm_group": {
            "arm_group_label": "Stereotactic ablative radiotherapy", 
            "arm_group_type": "Experimental", 
            "description": "Stereotactic ablative radiotherapy for unresectable hepatocellular carcinoma with size \u2264 5 cm and 3cm apart from gastrointestinal tract after incomplete trans-arterial chemo-embolization"
        }, 
        "brief_summary": {
            "textblock": "The standard treatment for hepatocellular carcinoma (HCC) is surgery, such as, by hepatic\n      resection or liver transplantation, but less than 20% of HCC patients are suitable for\n      surgery. In the remaining patients with inoperable and advanced HCC, trans-arterial\n      chemo-embolization (TACE) has been widely used but TACE alone rarely produces complete\n      response and commonly develops recurrence. Recently several small studies reported high\n      tumor response and local control rate after stereotactic ablative radiotherapy (SABR) alone\n      or with TACE for inoperable HCC. This study will evaluate SABR effect with 60 Gy in 3\n      fractionations for HCC with size of \u2264 5 cm and 3 cm apart from gastrointestinal tract."
        }, 
        "brief_title": "Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma \u2264 5 cm", 
        "completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Hepatocellular Carcinoma", 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma", 
                "Carcinoma, Hepatocellular"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female patients \u2265 18 years of age\n\n          -  Initially diagnosed or recurrent hepatocellular carcinoma (HCC)\n\n          -  Unresectable HCC\n\n          -  Cirrhotic status of Child Pugh class A or B7\n\n          -  Eastern Cooperative Oncology Group performance status 0 or 1\n\n          -  single or sum of multiple tumor \u2264 5 cm\n\n          -  HCC with 3 cm apart from gastrointestinal tract\n\n          -  The volume of uninvolved must be at least 1000 ml\n\n          -  Incomplete response after trans-arterial chemo-embolization of 1-5\n\n          -  A single lesion or multiple lesions including portal vein tumor thrombosis included\n             in radiation field with one or consecutive sessions of stereotactic body radiation\n             therapy (SBRT)\n\n          -  No evidence of an uncontrolled lesion at any other site\n\n          -  No evidence of complications of liver cirrhosis\n\n          -  No evidence of uncontrolled inter-current illness\n\n          -  Patient or guardian must be able to provide verbal and written informed consent\n\n        Exclusion Criteria:\n\n          -  Patient with previous history of abdominal radiation\n\n          -  Direct invasion to esophagus, stomach or colon by HCC"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "54", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01825824", 
            "org_study_id": "K-1205-001-005", 
            "secondary_id": [
                "KCT0000454", 
                "KROG 12-02", 
                "K-1205-001-005"
            ]
        }, 
        "intervention": {
            "arm_group_label": "Stereotactic ablative radiotherapy", 
            "description": "The HCC patients with size \u22645 cm and 3 cm apart from gastrointestinal tract will be included in this study. Total stereotactic ablative radiotherapy (SABR) doses will be 60 Gy in 3 fractionations. Patients receive 3 fractionations separated by >48 hours. At least 700 ml of normal liver (entire liver minus cumulative GTV) should not receive a total dose of > 17 Gy in three fractions. If volume of normal liver does not exceed 700 ml, at least 70% of normal liver should not receive a total dose of > 17 Gy. Dose of esophagus, stomach and intestine do not exceed 30 Gy.", 
            "intervention_name": "Stereotactic ablative radiotherapy", 
            "intervention_type": "Radiation", 
            "other_name": "Stereotactic body radiotherapy"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Hepatocellular carcinoma", 
            "Stereotactic ablative radiotherapy", 
            "Stereotactic body radiotherapy"
        ], 
        "lastchanged_date": "May 2, 2013", 
        "location": [
            {
                "contact": {
                    "email": "kmyang@dirams.re.kr", 
                    "last_name": "Kwang Mo Yang, MD"
                }, 
                "contact_backup": {
                    "email": "drasdf19@gmail.com", 
                    "last_name": "Chul Won Choi, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Busan", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Dongnam Institute of Radiological & Medical Sciences"
                }, 
                "investigator": [
                    {
                        "last_name": "Kwang Mo Yang, MD, PhD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Chul Won Choi, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "nmcro@chol.net", 
                    "last_name": "Won Yong Oh, MD, PhD"
                }, 
                "contact_backup": {
                    "email": "astraea00@naver.com", 
                    "last_name": "Sunmi Jo, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Busan", 
                        "country": "Korea, Republic of", 
                        "zip": "612-896"
                    }, 
                    "name": "Inje University Haeundae Paik Hospital"
                }, 
                "investigator": [
                    {
                        "last_name": "Won Young Oh, MD, PhD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Sunmi Jo, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "radio@schch.co.kr", 
                    "last_name": "Eun Seok Kim, MD, PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Cheonan", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Soon Chun Hyang University Hospital Cheonan"
                }, 
                "investigator": {
                    "last_name": "Eun Seok Kim, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Incheon", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Inha University Hospital"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Incheon", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Catholic University Incheon St. Mary's Hospital"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Samsung Medical Center"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "email": "mskim@kirams.re.kr", 
                    "last_name": "Mi-Sook Kim, MD, PhD", 
                    "phone": "82-2-970-1264"
                }, 
                "contact_backup": {
                    "email": "zzang11@kirams.re.kr", 
                    "last_name": "Won Il Jang, MD", 
                    "phone": "82-2-970-1262"
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "139-706"
                    }, 
                    "name": "Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences"
                }, 
                "investigator": [
                    {
                        "last_name": "Mi-Sook Kim, MD, PhD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Won Il Jang, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Da Hoon Jung, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Eun Kyoung Paik, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Kum Bae Kim, PhD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Chul Ju Han, MD PhD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Su Cheol Park, MD, PhD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Young Han Kim, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Sang Beom Kim, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Ki Young Yang, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Yeon Joo Kim, MD, PhD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Jin Kim, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "changaram@schmc.ac.kr", 
                    "last_name": "Ah Ram Chang, MD, PhD"
                }, 
                "contact_backup": {
                    "email": "tazzlove@gmail.com", 
                    "last_name": "Hye Jin Park, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "Soon Chun Hyang University Hospital Seoul"
                }, 
                "investigator": [
                    {
                        "last_name": "Ah Ram Chang, MD, PhD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Hye Jin Park, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "1", 
        "official_title": "Multicenter Phase II Study of Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma \u2264 5 cm", 
        "overall_contact": {
            "email": "mskim@kirams.re.kr", 
            "last_name": "Mi-Sook Kim, MD, PhD", 
            "phone": "82-2-970-1264"
        }, 
        "overall_contact_backup": {
            "email": "zzang11@kirams.re.kr", 
            "last_name": "Won Il Jang, MD", 
            "phone": "82-2-970-1262"
        }, 
        "overall_official": {
            "affiliation": "Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences", 
            "last_name": "Mi-Sook Kim, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Republic of Korea: Ministry of Food and Drug Safety", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "From the date of SABR to the date of local failure or last follow-up", 
            "measure": "Local control rate", 
            "safety_issue": "No", 
            "time_frame": "up to 1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01825824"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Korea Cancer Center Hospital", 
            "investigator_full_name": "Mi-Sook Kim", 
            "investigator_title": "Doctor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "From the date of SABR to the date of death or last follow-up", 
                "measure": "Overall survival rate", 
                "safety_issue": "No", 
                "time_frame": "up to 2 years"
            }, 
            {
                "description": "From the date of SABR to the date of first failure or last follow-up", 
                "measure": "Progression free survival rate", 
                "safety_issue": "No", 
                "time_frame": "up to 2 years"
            }, 
            {
                "description": "From the date of SABR to the date of Intrahepatic recurrence or last follow-up", 
                "measure": "Intrahepatic recurrence free survival rate", 
                "safety_issue": "No", 
                "time_frame": "up to 2 years"
            }, 
            {
                "description": "Adverse events using Common Terminology Criteria for Adverse Events (CTCAE) version 4.0; Classic radiation induced liver disease; Non-classic Classic radiation induced liver disease; Worsening of Child-Turcotte-Pugh score; Worsening of MELD score", 
                "measure": "Treatment related toxicity", 
                "safety_issue": "Yes", 
                "time_frame": "up to 1 year"
            }
        ], 
        "source": "Korea Cancer Center Hospital", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Dongnam Institute of Radiological & Medical Sciences", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Soon Chun Hyang University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Inje University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Inha University Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Incheon St.Mary's Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Samsung Medical Center", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Kyung Hee University Gangdong Hospital", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Korea Cancer Center Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}